Bio-Piracy and Foreign Patents: How Nepal is Reclaiming Its Indigenous Medicinal Knowledge

The anatomy of bio-piracy

The canonical cases are South Asian and instructive: turmeric — a wound-healing use documented in Indian tradition, patented in the US as an invention, revoked after years of expensive opposition; neem — the fungicidal use, patented in Europe, contested for a decade and ultimately lost by the patentees; basmati — the naming and breeding claims that triggered a continental dispute over an origin word. Each case required years of litigation and evidence-gathering to undo what a patent application had obtained in months — the asymmetry that makes prevention (documentation, consent, disclosure) worth any administrative cost.

Nepal's exposure is structural: the country's medicinal and aromatic plant wealth is internationally significant (yarsagumba, jatamansi, chiraito, and hundreds of traded species), community knowledge of uses is deep, and until recently none of it was documented in forms foreign patent systems could see. An undocumented tradition is, to a patent examiner, a blank page — and blank pages are where 'inventions' are found.

• Turmeric, neem, basmati — the regional precedents and their costs
• Undocumented knowledge = prior art nobody can cite
• Prevention (documentation) beats the cure (revocation litigation)

The counter-machinery Nepal is building

The Bill 2082 adds the domestic instruments the treaty base lacked: documentation (Sections 83–84's identification/documentation/protection/benefit-sharing machinery for TK and traditional cultural expressions — the databases and community registers that turn oral tradition into citable prior art), consent (access to TK for research or commercialisation requires the holder community's prior informed consent — extraction becomes agreement), benefit-sharing (commercialisation triggers negotiated returns to source communities — the Nagoya architecture), and disclosure (Section 85: inventions using genetic resources must disclose their origin and lawful access — a requirement that makes undocumented provenance a patent defect, not a free resource).

The Scotch Whisky decision (Mohini Hygiene Products v. SWA, 2025) supplies the judicial anchor for the whole architecture: the Supreme Court confirmed that treaty obligations (TRIPS, Paris Convention) apply directly in Nepalese law through the Treaty Act — meaning the protection of GI-linked knowledge and the unfair-competition rules against misappropriation are already enforceable, with the Bill's framework completing the administrative system.

For communities: documentation is the shield

The practical centre of the reclaim effort is community-level documentation: recording the knowledge — uses, preparations, species, practices — in registers and databases structured for legal visibility. Documented knowledge is prior art: it defeats foreign patent claims that would otherwise succeed, because a patent requires novelty and a database entry is citable. Nepal's TK documentation effort has been running for years (district-level inventories, community registers); the Bill's framework gives those records legal force — the difference between an archive and a shield.

The companion practice is consent discipline: communities approached for knowledge or resources (by researchers, bioprospectors, product developers) negotiate access through the framework's procedures — consent documented, terms recorded, benefit-sharing agreed. The negotiated deal is not a barrier to science; it is the mechanism that makes the science lawful, repeatable and compensated.

For businesses: clean provenance is a patent asset

For Nepal's herbal, pharmaceutical and cosmetics businesses — and any foreign partner sourcing from Nepal — the framework converts provenance into a compliance asset: products and inventions traceable to documented, consent-based access carry a chain of title that survives patent examination, export-market scrutiny (disclosure rules abroad) and consumer demands for ethical sourcing. Undocumented sourcing is now the liability: patent-defective domestically, disclosure-risky abroad, and increasingly a commercial-reputation question in the markets that pay premiums.

The compliance list for R&D touching Nepalese biodiversity: document the source (species, location, access date); secure lawful access under the framework's procedures; obtain and record community consent where TK guided the work; keep the chain clean through the product's life; and disclose properly in every patent application that touches the material. The turmeric and neem cases took years and fortunes to unwind; the paperwork that prevents them takes days and discipline.